Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-014794
Filing Date
2023-04-26
Accepted
2023-04-26 16:07:12
Documents
6
Period of Report
2023-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A antx-def14a-2022-final.htm DEF 14A 987290
2 GRAPHIC img81564255_0.jpg GRAPHIC 15040
3 GRAPHIC img81564255_1.jpg GRAPHIC 4297
4 GRAPHIC img81564255_2.jpg GRAPHIC 4297
5 GRAPHIC img81564255_3.jpg GRAPHIC 816291
6 GRAPHIC img81564255_4.jpg GRAPHIC 486818
  Complete submission text file 0000950170-23-014794.txt   2816305
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Filer) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41331 | Film No.: 23849748
SIC: 2834 Pharmaceutical Preparations